Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Alpha-1b adrenergic receptor | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 1A | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-1d adrenergic receptor | Starlite/ChEMBL | References |
Trypanosoma cruzi | trypanothione reductase, putative | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 1B | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-1a adrenergic receptor | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 1D | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP4 | 0.0141923 | 0.314834 | 1 |
Leishmania major | peptidylprolyl isomerase-like protein | 0.0141923 | 0.314834 | 1 |
Trypanosoma brucei | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.0141923 | 0.314834 | 1 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, FKBP-type , putative | 0.0141923 | 0.314834 | 0.5 |
Giardia lamblia | 70 kDa peptidylprolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Treponema pallidum | peptidyl-prolyl cis-trans isomerase, FKBP-type, 22 kDa (fklB) | 0.0141923 | 0.314834 | 1 |
Echinococcus multilocularis | fk506 binding protein | 0.0141923 | 0.314834 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.00761339 | 0.145811 | 0.430596 |
Plasmodium falciparum | thioredoxin reductase | 0.00761339 | 0.145811 | 0.430596 |
Trypanosoma cruzi | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Plasmodium falciparum | glutathione reductase | 0.00761339 | 0.145811 | 0.430596 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.00263827 | 0.0179914 | 0.0571455 |
Schistosoma mansoni | immunophilin | 0.0141923 | 0.314834 | 0.302281 |
Plasmodium vivax | glutathione reductase, putative | 0.00761339 | 0.145811 | 0.430596 |
Brugia malayi | Thioredoxin reductase | 0.00761339 | 0.145811 | 0.463135 |
Trypanosoma brucei | trypanothione reductase | 0.00761339 | 0.145811 | 0.430596 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.0129403 | 0.282667 | 0.891637 |
Leishmania major | fk506-binding protein 1-like protein | 0.0141923 | 0.314834 | 1 |
Trichomonas vaginalis | fk506-binding protein, putative | 0.0141923 | 0.314834 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.00761339 | 0.145811 | 1 |
Giardia lamblia | FKBP-type peptidyl-prolyl cis-trans isomerase | 0.0141923 | 0.314834 | 1 |
Leishmania major | trypanothione reductase | 0.00761339 | 0.145811 | 0.430596 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.00263827 | 0.0179914 | 0.5 |
Plasmodium vivax | 70 kDa peptidylprolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0129403 | 0.282667 | 0.80969 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-12 | 0.0141923 | 0.314834 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.00761339 | 0.145811 | 0.430596 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.0141923 | 0.314834 | 1 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP1A | 0.0141923 | 0.314834 | 1 |
Loa Loa (eye worm) | FKBP5 protein | 0.0141923 | 0.314834 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.00761339 | 0.145811 | 0.430596 |
Schistosoma mansoni | amine GPCR | 0.0408611 | 1 | 1 |
Schistosoma mansoni | immunophilin FK506 binding protein FKBP12 | 0.0141923 | 0.314834 | 0.302281 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.00263827 | 0.0179914 | 0.5 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-59, BmFKBP59 | 0.0141923 | 0.314834 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.00761339 | 0.145811 | 1 |
Trypanosoma cruzi | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.0141923 | 0.314834 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.00263827 | 0.0179914 | 0.5 |
Trichomonas vaginalis | immunophilin, putative | 0.0141923 | 0.314834 | 1 |
Mycobacterium ulcerans | FK-506 binding protein, peptidyl-prolyl cis-trans isomerase | 0.0141923 | 0.314834 | 1 |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase FKBP35 | 0.0141923 | 0.314834 | 1 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, FKBP-type, putative | 0.0141923 | 0.314834 | 0.5 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-12, BmFKBP-12 | 0.0141923 | 0.314834 | 1 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.0141923 | 0.314834 | 1 |
Brugia malayi | glutathione reductase | 0.00761339 | 0.145811 | 0.463135 |
Schistosoma mansoni | immunophilin | 0.0141923 | 0.314834 | 0.302281 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.0141923 | 0.314834 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.00761339 | 0.145811 | 0.430596 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.00263827 | 0.0179914 | 0.5 |
Schistosoma mansoni | immunophilin | 0.0129403 | 0.282667 | 0.269525 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP4 | 0.0129403 | 0.282667 | 0.891637 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.12 uM | Antitrypanosomal activity against Trypanosoma brucei rhodesiense bloodstream trypomastigotes | ChEMBL. | 19414258 |
IC50 (functional) | = 0.53 uM | Antibacterial activity against intraerythrocytic form of Plasmodium falciparum | ChEMBL. | 19414258 |
IC50 (functional) | = 1.78 uM | Antileishmanial activity against Leishmania donovani axenic amastigotes | ChEMBL. | 19414258 |
IC50 (functional) | = 2.63 uM | Antioxidant activity against formation of ROS was determined in t-BuOOH treated LNCaP cells after 24 h of incubation with compounds (1-100 uM) | ChEMBL. | 15633998 |
IC50 (functional) | = 2.63 uM | Antioxidant activity against formation of ROS was determined in t-BuOOH treated LNCaP cells after 24 h of incubation with compounds (1-100 uM) | ChEMBL. | 15633998 |
IC50 (functional) | = 3.68 uM | Antitrypanosomal activity against Trypanosoma cruzi amastigotes infected in rat L6 cells | ChEMBL. | 19414258 |
IC50 (functional) | = 8.82 uM | Antiproliferative activity was determined by colorimetric MTS assay in LNCaP cells after 72 h of incubation with compounds (1-100 uM) | ChEMBL. | 15633998 |
IC50 (functional) | = 8.82 uM | Antiproliferative activity was determined by colorimetric MTS assay in LNCaP cells after 72 h of incubation with compounds (1-100 uM) | ChEMBL. | 15633998 |
Inhibition (binding) | Inhibition of human glutathione reductase at 10 uM by spectrophotometry in presence of 100 uM GSSG | ChEMBL. | 19414258 | |
Inhibition (binding) | = 53 % | Inhibition of Trypanosoma cruzi recombinant trypanothione reductase at 25 uM by spectrophotometry using 50 uM trypanothione disulfide | ChEMBL. | 19414258 |
Inhibition (binding) | = 57 % | Inhibition of Trypanosoma cruzi recombinant trypanothione reductase at 25 uM by spectrophotometry using 100 uM trypanothione disulfide | ChEMBL. | 19414258 |
Kd (functional) | = 7.64 | Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoreceptor) | ChEMBL. | 15633998 |
Kd (functional) | = 8.51 | Blocking activity was assessed by antagonism of (-)-phenylephrine induced contraction of rat spleen (alpha1B adrenoreceptor) | ChEMBL. | 15633998 |
Kd (functional) | = 9.05 | Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat thoracic aorta (alpha1D adrenoreceptor) | ChEMBL. | 15633998 |
Ki (binding) | = -9.17 | Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]-prazosin to label cloned human alpha 1b expressed in CHO cells | ChEMBL. | 15633998 |
Ki (binding) | = -9.03 | Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]-prazosin to label cloned human alpha 1d expressed in CHO cells | ChEMBL. | 15633998 |
Ki (binding) | = -8.9 | Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]-prazosin to label cloned human alpha 1a expressed in CHO cells | ChEMBL. | 15633998 |
Ki (binding) | = 7.5 uM | Inhibition of Trypanosoma cruzi recombinant trypanothione reductase by spectrophotometry | ChEMBL. | 19414258 |
Ki (binding) | = 22 uM | Inhibition of Trypanosoma cruzi recombinant trypanothione reductase by spectrophotometry-based mixed inhibition type assay | ChEMBL. | 19414258 |
Log Ki (binding) | = 8.9 | Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]-prazosin to label cloned human alpha 1a expressed in CHO cells | ChEMBL. | 15633998 |
Log Ki (binding) | = 9.03 | Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]-prazosin to label cloned human alpha 1d expressed in CHO cells | ChEMBL. | 15633998 |
Log Ki (binding) | = 9.17 | Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]-prazosin to label cloned human alpha 1b expressed in CHO cells | ChEMBL. | 15633998 |
pA2 (functional) | = 7.64 | Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoreceptor) | ChEMBL. | 15633998 |
pA2 (functional) | = 8.51 | Blocking activity was assessed by antagonism of (-)-phenylephrine induced contraction of rat spleen (alpha1B adrenoreceptor) | ChEMBL. | 15633998 |
pA2 (functional) | = 9.05 | Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat thoracic aorta (alpha1D adrenoreceptor) | ChEMBL. | 15633998 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma brucei gambiense | 19414258 | ||
Trypanosoma cruzi | ChEMBL23 | 19414258 | |
Leishmania donovani | ChEMBL23 | 19414258 | |
Plasmodium falciparum | ChEMBL23 | 19414258 | |
Homo sapiens | ChEMBL23 | 15633998 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.